Items where authors include "Trichet, V."

Article

Avril, P., Le Nail, L.R., Brennan, M.Á. et al. (6 more authors) (2016) Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status. Journal of Bone Oncology, 5 (1). pp. 5-14. ISSN 2212-1366

Cordova, L.A., Trichet, V., Escriou, V. et al. (10 more authors) (2015) Inhibition of osteolysis and increase of bone formation after local administration of siRNA-targeting RANK in a polyethylene particle-induced osteolysis model. Acta Biomaterialia, 13. pp. 150-158. ISSN 1742-7061

Gamblin, A-L., Brennan, M.A., Renaud, A. et al. (5 more authors) (2014) Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: The local implication of osteoclasts and macrophages. Biomaterials, 35 (36). pp. 9660-9667. ISSN 0142-9612

Gamblin, A.L., Renaud, A., Charrier, C. et al. (5 more authors) (2014) Osteoblastic and osteoclastic differentiation of human mesenchymal stem cells and monocytes in a miniaturized three-dimensional culture with mineral granules. Acta Biomaterialia, 10 (12). pp. 5139-5147. ISSN 1742-7061

Brennan, M.A., Renaud, A., Amiaud, J. et al. (5 more authors) (2014) Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate. Stem Cell Research & Therapy, 5. 114. ISSN 1757-6512

Cordova, L.A., Stresing, V., Gobin, B. et al. (6 more authors) (2014) Orthopaedic implant failure: aseptic implant loosening--the contribution and future challenges of mouse models in translational research. Clinical Science, 127 (5). pp. 277-293. ISSN 0143-5221

Rousseau, J., Gioia, R., Layrolle, P. et al. (6 more authors) (2014) Allele-specific Col1a1 silencing reduces mutant collagen in fibroblasts from Brtl mouse, a model for classical osteogenesis imperfecta. European Journal of Human Genetics, 22 (5). pp. 667-674. ISSN 1018-4813

Picarda, G., Matous, E., Amiaud, J. et al. (8 more authors) (2013) Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKL. Journal of Bone Oncology, 2 (3). pp. 95-104. ISSN 2212-1374

Bouacida, A., Rosset, P., Trichet, V. et al. (7 more authors) (2012) Pericyte-Like Progenitors Show High Immaturity and Engraftment Potential as Compared with Mesenchymal Stem Cells. PLoS ONE, 7 (11). e48648. ISSN 1932-6203

Picarda, G., Surget, S., Guiho, R. et al. (7 more authors) (2012) A Functional, New Short Isoform of Death Receptor 4 in Ewing's Sarcoma Cell Lines May be Involved in TRAIL Sensitivity/Resistance Mechanisms. Molecular Cancer Research, 10 (3). pp. 336-346. ISSN 1541-7786

Picarda, G., Trichet, V., Teletchea, S. et al. (2 more authors) (2012) TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment. American Journal of Cancer Research, 2 (1). pp. 45-64. ISSN 2156-6976

Rousseau, J., Escriou, V., Lamoureux, F. et al. (8 more authors) (2011) Formulated siRNAs Targeting Rankl Prevent Osteolysis and Enhance Chemotherapeutic Response in Osteosarcoma Models. Journal of Bone and Mineral Research, 26 (10). pp. 2452-2462. ISSN 0884-0431

Perrot, P., Rousseau, J., Bouffaut, A-L. et al. (8 more authors) (2010) Safety Concern between Autologous Fat Graft, Mesenchymal Stem Cell and Osteosarcoma Recurrence. PLOS ONE, 5 (6). e10999. ISSN 1932-6203

Rousseau, J., Escriou, V., Perrot, P. et al. (6 more authors) (2010) Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models. Cancer Gene Therapy , 17 (6). pp. 387-397. ISSN 0929-1903

Brounais, B., David, E., Chipoy, C. et al. (8 more authors) (2009) Long term oncostatin M treatment induces an osteocyte-like differentiation on osteosarcoma and calvaria cells. Bone, 44 (5). pp. 830-839. ISSN 8756-3282

Georges, S., Veiasco, C.R., Trichet, V. et al. (3 more authors) (2009) Proteases and bone remodelling. Cytokine & Growth Factor Reviews, 20 (1). pp. 29-41. ISSN 1359-6101

Lamoureux, F., Picarda, G., Garrigue-Antar, L. et al. (7 more authors) (2009) Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma. Cancer Research, 69 (2). pp. 526-536. ISSN 0008-5472

Duplomb, L., Baud'huin, M., Charrier, C. et al. (4 more authors) (2008) Interleukin-6 inhibits receptor activator of nuclear factor kappa B ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: Key role of Serine(727) phosphorylation of signal transducer and activator of transcription 3. Endocrinology, 149 (7). pp. 3688-3697. ISSN 0013-7227

Ory, B., Moriceau, G.D., Trichet, V. et al. (5 more authors) (2008) Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells. J Cell Mol Med, 12 (3). pp. 928-941. ISSN 1582-1838

Chipoy, C., Brounais, B., Trichet, V. et al. (7 more authors) (2007) Sensitization of osteosarcoma cells to apoptosis by oncostatin M depends on STAT5 and p53. Oncogene, 26 (46). pp. 6653-6664. ISSN 0950-9232

Lamoureux, F., Richard, P., Wittrant, Y. et al. (8 more authors) (2007) Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: Blockade of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Research, 67 (15). pp. 7308-7318. ISSN 0008-5472